Autologous stem cell infusion for children with acquired hearing loss
Overview:
The trial is being undertaken at the Florida Hospital in Orlando,
Florida. The purpose of this study is to determine if autologous
(child’s own) umbilical cord blood infusion in children with
acquired hearing loss is safe, feasible, improves inner ear
function, audition and language development. Researchers aim to
enrol 10 children between 6 weeks to 6 years of age. All
participants will receive a single infusion of their own cord blood.
The estimated completion date for this study is January 2016.
Location: Florida, USA
Trial design: Safety study
Status: Open – recruiting
Find out more